Latest Articles
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ET Pharma
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty ET Pharma
Published: Jan. 10, 2026, 1:55 a.m.
Noah Donohoe: Death inquest date confirmed into Belfast schoolboy - BBC
Noah Donohoe: Death inquest date confirmed into Belfast schoolboy BBC
Published: Jan. 9, 2026, 1:35 p.m.
‘Misinformation spreads fast via personal stories’: Appraising the rise of Reddit for health advice - Women's Health
‘Misinformation spreads fast via personal stories’: Appraising the rise of Reddit for health advice Women's Health
Published: Jan. 9, 2026, 12:51 p.m.
Can Hertz Global Holdings Inc. stock outperform in 2025 bull market - Short Setup & Free Weekly Chart Analysis and Trade Guides - ulpravda.ru
Can Hertz Global Holdings Inc. stock outperform in 2025 bull market - Short Setup & Free Weekly Chart Analysis and Trade Guides ulpravda.ru
Published: Jan. 9, 2026, 4:33 a.m.
Will Schwab Fundamental Emerging Markets Equity stock outperform global peers - Trade Exit Report & Community Trade Idea Sharing - ulpravda.ru
Will Schwab Fundamental Emerging Markets Equity stock outperform global peers - Trade Exit Report & Community Trade Idea Sharing ulpravda.ru
Published: Jan. 8, 2026, 9:28 p.m.
Can LakeShore Biopharma Co. Ltd Equity Warrant stock outperform in 2025 bull market - Weekly Trade Review & Daily Volume Surge Signals - ulpravda.ru
Can LakeShore Biopharma Co. Ltd Equity Warrant stock outperform in 2025 bull market - Weekly Trade Review & Daily Volume Surge Signals ulpravda.ru
Published: Jan. 8, 2026, 2:18 p.m.
More details emerge of NHS online hospital due next year - Pharmaphorum
More details emerge of NHS online hospital due next year Pharmaphorum
Published: Jan. 6, 2026, 12:36 p.m.
More details emerge of NHS online hospital due next year - pharmaphorum
More details emerge of NHS online hospital due next year pharmaphorum
Published: Jan. 6, 2026, 12:36 p.m.
Autologous CD133+ Stem Cells Trial for Asherman - BIOENGINEER.ORG
Autologous CD133+ Stem Cells Trial for Asherman BIOENGINEER.ORG
Published: Jan. 3, 2026, 7:41 a.m.
Autologous CD133+ Stem Cells Trial for Asherman - Bioengineer.org
Autologous CD133+ Stem Cells Trial for Asherman Bioengineer.org
Published: Jan. 3, 2026, 7:41 a.m.
Link copied to clipboard!